Events & Promotions
|
|
GMAT Club Daily Prep
Thank you for using the timer - this advanced tool can estimate your performance and suggest more practice questions. We have subscribed you to Daily Prep Questions via email.
Customized
for You
Track
Your Progress
Practice
Pays
Not interested in getting valuable practice questions and articles delivered to your email? No problem, unsubscribe here.
Sep 0710:00 AM PDT
-11:00 AM PDT
A complete walkthrough of GMAT Club’s free 12-week GMAT study plan: what you study each week, how progress and goals are tracked, how the error log works, and how your practice unlocks paid tools at no cost.
Sep 0201:00 PM EDT
-11:59 PM EDT
Take 30% off all study plans with code COURSEWORK - Expires on Monday 9/7
Sep 0410:00 AM EDT
-11:59 PM EDT
We’ve worked incredibly hard to build TTP into the best test prep experience possible, and it would mean a lot to us to win Newsweek’s 2026 Readers’ Choice Award for Best Test Prep. If TTP has helped you, we’d be incredibly grateful for your vote.- Sep 07
12:01 AM PDT
-11:59 PM PDT
On the 7th, GMAT Club Tests will be Free! Including all the Quizzes, Questions, and Tests. 12 AM - 11:59 PM PDT - Sep 09
07:00 AM PDT
-10:00 AM PDT
Meet AdComs and explore top Master’s programs - MiM, MiF, MSc, MSBA and more. - Application Fee Waivers - Free 1-Week of GMAT Club Tests: - Master's Application Toolkit - Grand Prize Giveaway - Sep 09
10:00 AM PDT
-11:00 AM PDT
Three MBA applications. Three rejections. No interview invites. A year later, Aman was admitted to Cambridge Judge, SMU, and IMD. In this episode of MBA Admit Stories, Aman shares how he rebuilt his MBA application... 
Sep 1507:00 PM EDT
-09:00 PM EST
Elite scores are possible when you enroll in a powerful GMAT course, taught live online + 6 months access to TTP OnDemand video courses included! Class starts Tues/Thurs Sept. 15, 2026 - Nov. 15, 2027, 7:00pm-9:00pm EST
Sep 2108:00 PM EDT
-10:00 PM EDT
Boost your GMAT score in less than one month in a live online class + 6 months access to TTP OnDemand video courses included! Class starts Mon, Tues, Wed, Thur, Fri Sept. 21, 2026 - Oct. 9, 2027, 7:00pm-10:00pm EST
12 Aug 2026, 07:10
Kudos
Bookmarks
C
Be sure to select an answer first to save it in the Error Log before revealing the correct answer (OA)!
Difficulty:
55%
(hard)
Question Stats:
62% (01:45) correct
38%
(02:04)
wrong
based on 219
sessions
History
Date
Time
Result
Not Attempted Yet
Ethicist: Both ASA and TPA are clot-dissolving agents. Recent studies show that the more expensive agent, TPA, would save at most two more lives than would ASA out of every 50 cardiac patients to whom they are postoperatively administered. However, since the relatives of the patients who die simply because they were given the less expensive medicine would be particularly grieved, the financial saving involved in using ASA over TPA must also be weighed against such considerations.
Which one of the following most accurately expresses the conclusion of the ethicist's argument?
(A) ASA should never be given to postoperative cardiac patients in place of TPA.
(B) TPA is a slightly more effective clot-dissolving agent than ASA.
(C) The extra expense of TPA cannot be weighed simply against the few additional lives saved.
(D) ASA is a less expensive clot-dissolving agent than TPA.
(E) Relatives of a patient who has died grieve more if the patient received ASA rather than TPA.
Which one of the following most accurately expresses the conclusion of the ethicist's argument?
(A) ASA should never be given to postoperative cardiac patients in place of TPA.
(B) TPA is a slightly more effective clot-dissolving agent than ASA.
(C) The extra expense of TPA cannot be weighed simply against the few additional lives saved.
(D) ASA is a less expensive clot-dissolving agent than TPA.
(E) Relatives of a patient who has died grieve more if the patient received ASA rather than TPA.
12 Aug 2026, 14:45
Kudos
Bookmarks
Ethicist: Both ASA and TPA are clot-dissolving agents. Recent studies show that the more expensive agent, TPA, would save at most two more lives than would ASA out of every 50 cardiac patients to whom they are postoperatively administered. However, since the relatives of the patients who die simply because they were given the less expensive medicine would be particularly grieved, the financial saving involved in using ASA over TPA must also be weighed against such considerations.
Which one of the following most accurately expresses the conclusion of the ethicist's argument?
The ethicist accepts that TPA is more expensive and may save only a few more lives than ASA. The conclusion appears after “since” gives the supporting reason: because relatives would be particularly grieved when a patient dies specifically because the cheaper drug was used, the financial savings from ASA must be weighed against that consideration.
(A) ASA should never be given to postoperative cardiac patients in place of TPA.
Too strong. The ethicist does not say ASA should never be used.
(B) TPA is a slightly more effective clot-dissolving agent than ASA.
This is based on the study and serves as background, not the conclusion.
(C) The extra expense of TPA cannot be weighed simply against the few additional lives saved.
Correct. This captures the conclusion that financial cost cannot be considered alone; the additional grief caused by preventable deaths must also be taken into account.
(D) ASA is a less expensive clot-dissolving agent than TPA.
This is background information, not the conclusion.
(E) Relatives of a patient who has died grieve more if the patient received ASA rather than TPA.
This is not the conclusion. It reflects the reason used to support the conclusion. Also, the passage does not say relatives of every patient who received ASA would grieve more. It refers specifically to patients who died because they were given the less expensive drug.
Answer: (C)
Which one of the following most accurately expresses the conclusion of the ethicist's argument?
The ethicist accepts that TPA is more expensive and may save only a few more lives than ASA. The conclusion appears after “since” gives the supporting reason: because relatives would be particularly grieved when a patient dies specifically because the cheaper drug was used, the financial savings from ASA must be weighed against that consideration.
(A) ASA should never be given to postoperative cardiac patients in place of TPA.
Too strong. The ethicist does not say ASA should never be used.
(B) TPA is a slightly more effective clot-dissolving agent than ASA.
This is based on the study and serves as background, not the conclusion.
(C) The extra expense of TPA cannot be weighed simply against the few additional lives saved.
Correct. This captures the conclusion that financial cost cannot be considered alone; the additional grief caused by preventable deaths must also be taken into account.
(D) ASA is a less expensive clot-dissolving agent than TPA.
This is background information, not the conclusion.
(E) Relatives of a patient who has died grieve more if the patient received ASA rather than TPA.
This is not the conclusion. It reflects the reason used to support the conclusion. Also, the passage does not say relatives of every patient who received ASA would grieve more. It refers specifically to patients who died because they were given the less expensive drug.
Answer: (C)
